Today: 3 July 2026
Browse Category

Stock Market 12 January 2026

Arcutis Biotherapeutics stock slides after 2026 ZORYVE sales outlook; June FDA deadline in focus

Arcutis Biotherapeutics stock slides after 2026 ZORYVE sales outlook; June FDA deadline in focus

New York, January 12, 2026, 15:41 ET — Regular session Shares of Arcutis Biotherapeutics dropped 8.7% on Monday, slipping $2.46 to $25.76, following the company’s update on its 2026 priorities. The dermatology drugmaker set a $455 million to $470 million target for net product sales in its ZORYVE franchise. The stock hit a session low of $25.51 during trading.
12 January 2026
··
Credo Technology (CRDO) stock climbs as AI-chip trade stays hot; Needham conference next

Credo Technology (CRDO) stock climbs as AI-chip trade stays hot; Needham conference next

NEW YORK, Jan 12, 2026, 15:19 EST — Regular session Shares of Credo Technology Group Holding Ltd climbed 3.1% to $155.10 in Monday afternoon trading, bouncing between $145.35 and $156.43 earlier. The Nasdaq-listed company, with a market cap near $32.5 billion, trades at a triple-digit trailing price-to-earnings ratio as AI-driven semiconductor enthusiasm pushes valuations higher.
12 January 2026
···
Figure Technology Solutions stock drops nearly 10% after FIGR posts preliminary Q4 loan data

Figure Technology Solutions stock drops nearly 10% after FIGR posts preliminary Q4 loan data

New York, Jan 12, 2026, 15:09 EST — Regular session Shares of Figure Technology Solutions, Inc. dropped steeply on Monday following the release of preliminary Q4 operating data, offering a first glimpse into its loan marketplace and crypto-related offerings. The Nasdaq-listed stock slipped 9.6% to $52.50, hitting a low of $49.10 and peaking near $58.67 earlier in the session.
12 January 2026
··
SoFi stock slides as CEO Anthony Noto weighs Trump’s 10% credit-card rate cap

SoFi stock slides as CEO Anthony Noto weighs Trump’s 10% credit-card rate cap

New York, January 12, 2026, 14:50 EST — Regular session Shares of SoFi Technologies dropped 2.4% to $26.74 in afternoon trading Monday, wiping out earlier gains. The slide came after CEO Anthony Noto highlighted potential growth in personal loans tied to President Donald Trump’s plan to cap credit-card rates. The stock had climbed as high as $28.05 before dipping to a low of $26.22.
12 January 2026
··
Nike stock dips even after Jefferies’ “buy aggressively” call — what NKE investors are watching next

Nike stock dips even after Jefferies’ “buy aggressively” call — what NKE investors are watching next

New York, Jan 12, 2026, 14:43 EST — Regular session Nike shares dropped 0.6% to $65.52 in Monday afternoon trading, despite Jefferies reaffirming its buy rating and naming the sportswear giant its top large-cap pick for 2026. Analyst Randal Konik said he “would buy shares aggressively” ahead of this week’s ICR consumer conference and maintained a $110 price target.
12 January 2026
··
1 … 785 786 787 788 789 … 1,614

Stock Market Today

  • GPC Jumps 12.9% as O'Reilly Looks to Buy Auto Unit, Market Eyes Industrial Shift
    July 3, 2026, 5:13 AM EDT. Genuine Parts (GPC) shares soared 12.9% to $132.57 after news hit of O'Reilly Automotive's cash bid topping $10 billion for its auto-parts segment. The reported offer puts a spotlight on GPC's move to tighten its focus on the industrial parts business, where management targets better margins and growth. Even with a big stock surge, analysts left the consensus EPS at $2.10 for next quarter. Revenue is forecast up 3.6% to $6.39 billion from last year. Some say GPC may not hold onto gains unless earnings estimates start to climb. GPC is still rated Zacks Rank #3 (Hold). Over at Driven Brands Holdings (DRVN), shares added 2.6%, with its EPS estimate nudged up over the past month.
Go toTop